Afya Limited share price today

Afya Limited's share price was $10.50 at the close on 4 November 2026. That is 25.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between $10 and $16, and at that close it sat 1% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). The phase helps read everything below.

Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 2 weeks running.

Over the last 1 year the share price moved −33% while the S&P 500 moved +23%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Afya Limited declared ₹3.45 per local share for Dec 2025. It reports in its home currency, and one US-listed share can stand for several local shares, so we do not set this against the dollar price or show a yield.

Afya Limited is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Afya Limited earned ₹0.2 B of net profit in the Jun 2026 quarter, +14.4% on the same quarter a year earlier. That is the 12th quarter in a row of profit growth. Full-year FY25 profit was ₹0.8 B. Over 4 years profit has grown 35.5% a year on average. That is 20.3% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹0.2 B.

For the full year, FY25 profit was ₹0.8 B (+19.2% on the year before).

Why profit moved: revenue changed +5.7% on a year earlier and the margin moved −0.4 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +15.3% and revenue +7.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted.

Afya Limited reported ₹1.0 B of revenue in the Jun 2026 quarter, +5.7% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 21.1% a year on average. The last full year, FY25, came in at ₹3.7 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹3.8 B.

FY25 revenue was ₹3.7 B, +11.9% on the year before.

Recent pace: the last four quarters grew +7.9% on average, against 21.1% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +7.9%, against +11.7% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +12.7%, against +18.9% a year (rolling over).

This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted.

Afya Limited's operating margin was 30.6% in the Jun 2026 quarter, 0.4 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 25.6% and 32.9%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Across 5 years it has been between 25.6% and 32.9%, and FY25's 32.9% is the highest of them.

Why the margin moved: operating margin changed −0.4 percentage points on the year while gross margin changed −1.1 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold.

Over the last 3 years, 226% of Afya Limited's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in ₹1.5 B of operating cash against ₹0.8 B of profit. After ₹0.2 B of spending on assets, ₹1.4 B was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: it spends almost nothing on new assets, so the cash goes on running the business. The next section shows the spending figures.

This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted.

Afya Limited does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent ₹0.0 B on assets over the last 3 years. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Spending on assets: ₹0.0 B over the last 3 years.

In short: almost nothing is being spent on new assets, so the cash goes on running the business.

This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted.

Afya Limited's P/E is 6.3×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.

Afya Limited's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE steady at 16.0%; each line tells part of the story. This is based on 12 quarters of 3 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: when the lines disagree, each line above matters more than any single label.

This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Afya Limited earned a ROE of 15% in FY25. That is up from a low of 7% in FY21. Its return on capital used (ROIC) is left out: on sales this small it reads 16%, a number that says nothing useful about the business. It comes from a 20.4% net margin and 0.40× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 20.4% net margin × 0.40× asset turnover × 1.91× leverage (assets divided by equity) ≈ 15.6% on equity. The margin does most of the work; borrowing is a big part of it.

Afya Limited has total debt of ₹3.1 B against shareholder equity of ₹4.9 B as of Jun 2026, so its debt is 0.63× its equity. Year by year, that ratio went from 0.72 in FY21 to 0.64 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted.

We have no ownership or short-position figures for Afya Limited, so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 0.9 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

For Afya Limited, the Z-score is 2.37. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 2.37 is in the grey area, neither clearly safe nor clearly in trouble.

There is no score against its industry: Afya Limited is not among the largest members shown in this industry comparison for Education & Training Services.

The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown.

No sector comparison is shown here, not among the largest members shown in this industry comparison.

Afya Limited is the 14th largest of 20 Education & Training Services companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Strategic Education, Inc., Universal Technical Institute, Inc. and Coursera, Inc. Just below it: Phoenix Education Partners, Inc., American Public Education, Inc. and Lincoln Educational Services Corporation.

Education & Training Services companies close in size

11. Strategic Education, Inc. $1.6 billion
12. Universal Technical Institute, Inc. $1.2 billion
13. Coursera, Inc. $1 billion
14. Afya Limited $929 million
15. Phoenix Education Partners, Inc. $794 million
16. American Public Education, Inc. $776 million
17. Lincoln Educational Services Corporation $638 million

All 20 Education & Training Services companies, largest first

Companies close in size in other industries

2476. Odyssey Therapeutics, Inc. $934 million · Biotechnology
2477. Barings BDC, Inc. $933 million · Asset Management
2478. Afya Limited $929 million
2479. GCI Liberty, Inc. $928 million · Telecom Services
2480. NB Bancorp, Inc. $928 million · Banks - Regional

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.